TY - JOUR
T1 - Caspase 2 in mitotic catastrophe
T2 - The terminator of aneuploid and tetraploid cells
AU - Vitale, Ilio
AU - Manic, Gwenola
AU - Castedo, Maria
AU - Kroemer, Guido
N1 - Publisher Copyright:
© 2017, © 2017 Taylor & Francis Group, LLC.
PY - 2017/5/4
Y1 - 2017/5/4
N2 - Mitotic catastrophe is an oncosuppressive mechanism that targets cells experiencing defective mitoses via the activation of specific cell cycle checkpoints, regulated cell death pathways and/or cell senescence. This prevents the accumulation of karyotypic aberrations, which otherwise may drive oncogenesis and tumor progression. Here, we summarize experimental evidence confirming the role of caspase 2 (CASP2) as the main executor of mitotic catastrophe, and we discuss the signals that activate CASP2 in the presence of mitotic aberrations. In addition, we summarize the main p53-dependent and -independent effector pathways through which CASP2 limits chromosomal instability and non-diploidy, hence mediating robust oncosuppressive functions.
AB - Mitotic catastrophe is an oncosuppressive mechanism that targets cells experiencing defective mitoses via the activation of specific cell cycle checkpoints, regulated cell death pathways and/or cell senescence. This prevents the accumulation of karyotypic aberrations, which otherwise may drive oncogenesis and tumor progression. Here, we summarize experimental evidence confirming the role of caspase 2 (CASP2) as the main executor of mitotic catastrophe, and we discuss the signals that activate CASP2 in the presence of mitotic aberrations. In addition, we summarize the main p53-dependent and -independent effector pathways through which CASP2 limits chromosomal instability and non-diploidy, hence mediating robust oncosuppressive functions.
KW - Chromosome instability
KW - mitotic slippage
KW - polyploidy
KW - replication stress
KW - spindle assembly checkpoint
KW - targeted cancer therapy
UR - http://www.scopus.com/inward/record.url?scp=85032490069&partnerID=8YFLogxK
U2 - 10.1080/23723556.2017.1299274
DO - 10.1080/23723556.2017.1299274
M3 - Comment/debate
AN - SCOPUS:85032490069
SN - 2372-3556
VL - 4
JO - Molecular and Cellular Oncology
JF - Molecular and Cellular Oncology
IS - 3
M1 - e1299274
ER -